Rheumatology Trials Seem Vulnerable to Unblinding: Report

Until more is known about the potential for unblinding, clinicians need to keep in mind that patients and physicians could often guess accurately who was getting placebo or active drug.
MDedge News

source https://www.medscape.com/s/viewarticle/rheumatology-trials-unblinding-seem-vulnerable-2023a1000k1w?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost